The leukemogenic action of phorbol.
D000818:Animals; D000873:Anthracenes / Q000008:administration & dosage; D003436:Croton Oil / Q000008:administration & dosage; D004357:Drug Synergism; D005260:Female; D007274:Injections, Intraperitoneal; D007680:Kidney Neoplasms / Q000473:pathology; D007942:Leukemia, Experimental / Q000139:chemically induced / Q000453:epidemiology / Q000473:pathology; D007945:Leukemia, Lymphoid / Q000139:chemically induced* / Q000453:epidemiology / Q000473:pathology; D008113:Liver Neoplasms / Q000473:pathology; D008223:Lymphoma / Q000139:chemically induced / Q000453:epidemiology / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000139:chemically induced / Q000453:epidemiology / Q000473:pathology; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000453:epidemiology / Q000473:pathology; D012867:Skin / Q000293:injuries; D012878:Skin Neoplasms / Q000473:pathology; D013160:Splenic Neoplasms / Q000473:pathology; D013997:Time Factors
D000873:Anthracenes; D003436:Croton Oil